Le Lézard
Classified in: Health
Subject: SCZ

NANASP Statement on Pneumococcal Vaccine Recommendation Vote


WASHINGTON, June 26, 2019 /PRNewswire/ -- The National Association of Nutrition and Aging Services Programs (NANASP) issued the following statement regarding today's vote by the Advisory Committee on Immunization Practices on pneumococcal vaccination recommendations for adults aged 65+:

"We are pleased that members of the Advisory Committee on Immunization Practices today at their semi-annual meeting in Atlanta, GA voted down a proposal to completely eliminate a key pneumococcal disease vaccination for older Americans. However, we have concerns that the shared clinical decision-making recommendation that was approved will lead to confusion among healthcare providers and most importantly, patients.  

Pneumococcal disease is among the deadliest diseases for adults aged 65 and older, and as one of the largest national organizations dedicated to protecting that population's health and well-being, we have concerns that this change will result in more seniors contracting pneumococcal disease.  Each year, approximately 18,000 Americans die from pneumococcal disease and its complications.

By changing the recommendation to "shared clinical decision-making," we understand that ACIP is trying to send a positive signal to continue vaccinations based on patient-doctor discussions. However, any change to the recommendation could lead to confusion among patients, with many seniors not being able to access a vaccine that works. It could also cause a reversal in Medicare coverage for the vaccine.

At a time when the value of vaccines is more important than ever, ACIP has sent a confusing message to the American people, and especially to those over the age of 65. With two new vaccines set for release in about two years, we had hoped that ACIP would stay the course to reassure seniors on this vital public health issue. We will continue to work with ACIP."

Contact: 
Meredith Ponder Whitmire
202-789-0470
[email protected] 

SOURCE National Association of Nutrition and Aging Services Programs


These press releases may also interest you

at 08:50
Response Pharmaceuticals, Inc., a clinical stage company focused on weight management and metabolic health in high-risk populations, today announced positive topline results from its Phase 1b clinical trial evaluating the safety and efficacy of...

at 08:47
Dr. Mary C. McCluskey, psychotherapist, and author revitalizes Dr. Alfred Adler, the "Pioneer in the Prevention of Mental Health Disorders" and Dr. Pierre Janet "Father of Trauma Treatment Theory" using a time-traveling hot air balloon to create a...

at 08:45
The "Peptide Synthesis: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of...

at 08:45
Ligand Pharmaceuticals Incorporated today announced that it will report first quarter 2024 financial results after the close of the U.S. financial markets on Tuesday, May 7, 2024, and will hold a conference call at 4:30 p.m. Eastern Time that same...

at 08:45
The National Foundation for Infectious Diseases (NFID) and technology company Fraym are partnering on a pilot project to deliver novel, hyperlocal insights to empower public health stakeholders working to increase vaccine uptake across the US....

at 08:44
BioPhotas Inc., manufacturers of the award-winning Celluma SERIES of light therapy devices, recently welcomed Annet King as its new Vice President of Global Sales. Annet has more than 25 years of clinical education and sales management experience and...



News published on and distributed by: